Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Attenuated familial adenomatous polyposis (AFAP) is a mild form of familial adenomatous polyposis characterized by the presence of fewer than 100 adenomatous colonic polyps, a more proximal colonic location, a delayed age of colorectal cancer (CRC) onset and a more limited expression of the extracolonic features.
Features include very common findings: Colorectal polyposis; and common findings: Colon cancer, Multiple gastric polyps, Duodenal polyposis, and Adenomatous colonic polyposis and others. 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 2 | Large intestinal polyposis, Gastrointestinal carcinoma |
Biomarker and diagnostic research for attenuated familial adenomatous polyposis has been reported in the published literature.
Phenotype severity distribution: 1 very common feature, 7 common features.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
13 publications have been identified in PubMed for attenuated familial adenomatous polyposis. Research spans Case Report / Case Series (23%), Epidemiology / Natural History (23%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 3 | 23% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 8:59 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Hormones
2 |
Thyroid adenoma, Papillary thyroid carcinoma |
Kidneys and urinary system | 1 | Multiple renal cysts |
Disease patterns and progression |
3 |
23% |
Testing and diagnosis research | 2 | 15% |
Laboratory research | 2 | 15% |
Research summaries | 1 | 8% |
Clinical study results | 1 | 8% |
New treatment approaches | 1 | 8% |
Forte G (2026). [PMID: 41595623](https://pubmed.ncbi.nlm.nih.gov/41595623/). *Biomedicines*. [Gene Therapy / Novel Therapeutics]
Tóth T (2026). [PMID: 41551532](https://pubmed.ncbi.nlm.nih.gov/41551532/). *World J Gastroenterol*. [Clinical Trial Publication]
Karstensen JG (2026). [PMID: 42101961](https://pubmed.ncbi.nlm.nih.gov/42101961/). *APMIS*. [Review / Meta-Analysis]
Costanzi A (2026). [PMID: 41987631](https://pubmed.ncbi.nlm.nih.gov/41987631/). *Ann Ital Chir*. [Case Report / Case Series]
Feldman D (2025). [PMID: 39932215](https://pubmed.ncbi.nlm.nih.gov/39932215/). *Dis Colon Rectum*. [Epidemiology / Natural History]
Chan-Pak-Choon F (2025). [PMID: 40879644](https://pubmed.ncbi.nlm.nih.gov/40879644/). *J Pathol*. [Case Report / Case Series]
García-Simón N (2025). [PMID: 39661238](https://pubmed.ncbi.nlm.nih.gov/39661238/). *Clin Transl Oncol*. [Diagnostic / Biomarker]
Makutani Y (2025). [PMID: 41395568](https://pubmed.ncbi.nlm.nih.gov/41395568/). *Int Cancer Conf J*. [Diagnostic / Biomarker]
Church J (2025). [PMID: 40192136](https://pubmed.ncbi.nlm.nih.gov/40192136/). *Dis Colon Rectum*. [Epidemiology / Natural History]
Wei R (2025). [PMID: 39828123](https://pubmed.ncbi.nlm.nih.gov/39828123/). *Cancer Lett*. [Basic Science / Preclinical]